Comparison

Anti-Mouse CD120b (TNFR2) [TR75-54.7] – DyLight® 488 - 100 µg

Item no. LEIN-T627-100ug
Manufacturer Leinco Technologies
Amount 100 ug
Quantity options 100 ug 200 ug 50 ug
Category
Type Antibody Monoclonal
Applications FC
Clone TR75-54.7
Specific against Mouse (Murine, Mus musculus)
Host Hamster - Armenian
Citations 1. Zuckerman, KS. et al. (1998) Cancer Res. 58: 2217
2. Chan, FKM. et al. (2000) Science 288:2351
3. Loetscher, H. et al. (1990) Cell 61:351
4. Rothe, J. et al. (1993) Nature 364:798
NCBI 21938
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Category
Primary Monoclonal Antibodies>Apoptosis & Cell Biology
Manufacturer - Targets
TNFR2
Country of Origin
USA
Shipping Temperature
Next Day 2 - 8°C
Storage Conditions
This DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze.
Product Description
Tumor necrosis factor receptor II (TNF-RII) or CD120b is a 75kD type I transmembrane protein present on most cell types at low levels1 including endothelial cells, cardiac myocytes and prostate cells2; the expression is upregulated upon activation. This receptor binds both TNF-α & TNF-β (aka. LT-α). In association with TRAF1 and TRAF2, the receptor crosslinking induced by TNF-α or LT-α trimers is critical for signal transduction, leading to apoptosis, NF-kB activation, increased expression of proinflammatory genes, tumor necrosis, and cell differentiation depending on cell type and differentiation state. The TR75-54.7 antibody has been shown to block ligand-induced receptor signaling.
Background
Tumor necrosis factor receptor II (TNF-RII) or CD120b is a 75kD type I transmembrane protein present on most cell types at low levels1 including endothelial cells, cardiac myocytes and prostate cells2; the expression is upregulated upon activation. This receptor binds both TNF-α & TNF-β (aka. LT-α). In association with TRAF1 and TRAF2, the receptor crosslinking induced by TNF-α or LT-α trimers is critical for signal transduction, leading to apoptosis, NF-kB activation, increased expression of proinflammatory genes, tumor necrosis, and cell differentiation depending on cell type and differentiation state. The TR75-54.7 antibody has been shown to block ligand-induced receptor signaling.
PubMed
TNFR2
Excitation Laser
Blue Laser (493 nm)
Manufacturer - Research Area
Immunology, Innate Immunity
Manufacturer - Specificity
Armenian Hamster Anti-Mouse Tumor Necrosis Factor Receptor II (TNF RII) (Clone TR75-54.7) recognizes an epitope on Mouse TNF RII. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
RRID
AB_2832074
Concentration
0.2 mg/ml
Formulation
This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen
E. coli -expressed mouse Type II TNFR
Additional Information
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Keywords
Monoclonal Antibody, Tumor Necrosis Factor Receptor II, TNFRSF1B, p75, CD120b, TBPII, TNF-R75, TNFBR, TNFR2, TNFR80, p75TNFR, TR75-54.7, TNF RII, Mouse CD120b, Anti-Mouse TNF RII

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close